175 related articles for article (PubMed ID: 8408666)
1. Chemotherapy induced nausea and emesis in pediatric cancer patients: external validity of child and parent emesis ratings.
Tyc VL; Mulhern RK; Fairclough D; Ward PM; Relling MV; Longmire W
J Dev Behav Pediatr; 1993 Aug; 14(4):236-41. PubMed ID: 8408666
[TBL] [Abstract][Full Text] [Related]
2. Acute and delayed nausea and emesis control in pediatric oncology patients.
Holdsworth MT; Raisch DW; Frost J
Cancer; 2006 Feb; 106(4):931-40. PubMed ID: 16404740
[TBL] [Abstract][Full Text] [Related]
3. A prospective assessment of chemotherapy-related nausea and vomiting in children with cancer.
Zeltzer LK; LeBaron S; Zeltzer PM
Am J Pediatr Hematol Oncol; 1984; 6(1):5-16. PubMed ID: 6711763
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the emetogenic potential of intrathecal chemotherapy and response to prophylactic treatment with ondansetron.
Holdsworth MT; Raisch DW; Winter SS; Chavez CM
Support Care Cancer; 1998 Mar; 6(2):132-8. PubMed ID: 9540172
[TBL] [Abstract][Full Text] [Related]
5. Development and validation of the pediatric nausea assessment tool for use in children receiving antineoplastic agents.
Dupuis LL; Taddio A; Kerr EN; Kelly A; MacKeigan L
Pharmacotherapy; 2006 Sep; 26(9):1221-31. PubMed ID: 16945043
[TBL] [Abstract][Full Text] [Related]
6. Comparable safety and antiemetic efficacy of a brief (30-second bolus) intravenous granisetron infusion and a standard (15-minute) intravenous ondansetron infusion in breast cancer patients receiving moderately emetogenic chemotherapy.
Perez EA; Lembersky B; Kaywin P; Kalman L; Yocom K; Friedman C
Cancer J Sci Am; 1998; 4(1):52-8. PubMed ID: 9467047
[TBL] [Abstract][Full Text] [Related]
7. Antiemetic efficacy of three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma.
Slabý J; Trnený M; Procházka B; Klener P
Neoplasma; 2000; 47(5):319-22. PubMed ID: 11130251
[TBL] [Abstract][Full Text] [Related]
8. Assessment of chemotherapy-induced emesis and evaluation of a reduced-dose intravenous ondansetron regimen in pediatric outpatients with leukemia.
Holdsworth MT; Raisch DW; Duncan MH; Chavez CM; Leasure MM
Ann Pharmacother; 1995 Jan; 29(1):16-21. PubMed ID: 7711340
[TBL] [Abstract][Full Text] [Related]
9. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
[TBL] [Abstract][Full Text] [Related]
10. Anticipatory nausea and vomiting in pediatric cancer patients.
Dolgin MJ; Katz ER; McGinty K; Siegel SE
Pediatrics; 1985 Mar; 75(3):547-52. PubMed ID: 3975125
[TBL] [Abstract][Full Text] [Related]
11. Comparison of tropisetron and granisetron in the control of nausea and vomiting in children receiving combined cancer chemotherapy.
Aksoylar S; Akman SA; Ozgenç F; Kansoy S
Pediatr Hematol Oncol; 2001 Sep; 18(6):397-406. PubMed ID: 11554235
[TBL] [Abstract][Full Text] [Related]
12. Measuring chemotherapy-induced nausea and emesis.
Martin CG; Rubenstein EB; Elting LS; Kim YJ; Osoba D
Cancer; 2003 Aug; 98(3):645-55. PubMed ID: 12879484
[TBL] [Abstract][Full Text] [Related]
13. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America.
Poli-Bigelli S; Rodrigues-Pereira J; Carides AD; Julie Ma G; Eldridge K; Hipple A; Evans JK; Horgan KJ; Lawson F;
Cancer; 2003 Jun; 97(12):3090-8. PubMed ID: 12784346
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy.
Warr DG; Hesketh PJ; Gralla RJ; Muss HB; Herrstedt J; Eisenberg PD; Raftopoulos H; Grunberg SM; Gabriel M; Rodgers A; Bohidar N; Klinger G; Hustad CM; Horgan KJ; Skobieranda F
J Clin Oncol; 2005 Apr; 23(12):2822-30. PubMed ID: 15837996
[TBL] [Abstract][Full Text] [Related]
15. The oral NK(1) antagonist aprepitant for the prevention of acute and delayed chemotherapy-induced nausea and vomiting: Pooled data from 2 randomised, double-blind, placebo controlled trials.
Warr DG; Grunberg SM; Gralla RJ; Hesketh PJ; Roila F; Wit Rd; Carides AD; Taylor A; Evans JK; Horgan KJ
Eur J Cancer; 2005 Jun; 41(9):1278-85. PubMed ID: 15939263
[TBL] [Abstract][Full Text] [Related]
16. Parameters that influence the outcome of nausea and emesis in cisplatin based chemotherapy.
Tsavaris N; Kosmas C; Mylonakis N; Bacoyiannis C; Kalergis G; Vadiaka M; Boulamatsis D; Iakovidis V; Kosmidis P
Anticancer Res; 2000; 20(6C):4777-83. PubMed ID: 11205218
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study.
Booth CM; Clemons M; Dranitsaris G; Joy A; Young S; Callaghan W; Trudeau M; Petrella T
J Support Oncol; 2007 Sep; 5(8):374-80. PubMed ID: 17944146
[TBL] [Abstract][Full Text] [Related]
18. Chlorpromazine with and without lorazepam as antiemetic therapy in children receiving uniform chemotherapy.
Relling MV; Mulhern RK; Fairclough D; Baker D; Pui CH
J Pediatr; 1993 Nov; 123(5):811-6. PubMed ID: 8229497
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy of granisetron as anti-emetic agent for emesis induced by intra-arterial injection therapy for hepatocellular carcinoma].
Ichida T; Isokawa O; Itoh S; Ohta H; Takagi K; Hatakeyama S; Tsuruya T; Doya Y; Nozawa A; Hata K; Hara H; Hirose S; Watanabe T; Asakura H
Gan To Kagaku Ryoho; 1998 Oct; 25(12):1939-46. PubMed ID: 9797817
[TBL] [Abstract][Full Text] [Related]
20. A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy.
Yeo W; Mo FK; Suen JJ; Ho WM; Chan SL; Lau W; Koh J; Yeung WK; Kwan WH; Lee KK; Mok TS; Poon AN; Lam KC; Hui EK; Zee B
Breast Cancer Res Treat; 2009 Feb; 113(3):529-35. PubMed ID: 18327706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
